CPT® Code 84233

A receptor assay is a laboratory test conducted to evaluate the presence of specific hormone receptors on tumor cells, which is crucial in determining the potential effectiveness of hormone therapy for cancer treatment. In the context of CPT® Code 84233, the focus is on the estrogen receptor assay, specifically performed on breast cancer cells. This assay assesses whether estrogen receptors are present on the cancer cells, which is significant because normal breast cells, as well as certain breast cancer cells, can be influenced by estrogen. Estrogen receptors are specialized proteins that bind to estrogen circulating in the bloodstream, facilitating communication that influences cell growth and reproductive functions. When breast cancer cells are classified as estrogen receptor positive, it indicates that these cells possess estrogen receptors and are likely to respond favorably to hormone therapies, which may include anti-estrogen medications or surgical interventions such as oophorectomy (removal of the ovaries). Conversely, breast cancer cells that are estrogen receptor negative lack these receptors and typically do not respond well to hormone therapy, making the receptor assay a vital component in guiding treatment decisions. This distinction is essential for tailoring effective treatment strategies for patients with breast cancer, as it directly impacts the choice of therapeutic options available to them.